Latest News of PFE
Pfizer Inc. (PFE) Acquires Seagen for $43 Billion, Strengthening Oncology Leadership
The article discusses the top healthcare stocks favored by hedge funds, with a focus on Pfizer Inc. (NYSE:PFE). Healthcare sector investments are resilient, with rising global healthcare spending and ...
Here is What Jim Cramer Likes Pfizer Inc. (NYSE:PFE)
Jim Cramer's latest portfolio includes Pfizer Inc. as the 3rd top stock to buy. Cramer emphasizes the importance of recession-proof stocks amid aggressive rate cuts. Pfizer's potential growth catalyst...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com highlights Pfizer as a top stock pick, focusing on factors affecting its performance. Their analysis revolves around earnings projections and stock valuation, predicting positive outcomes du...
-
Pfizer Inc. (PFE): Why Are Street Analysts Bullish On This Wide Moat Stock Now?
By Yahoo! Finance | 6 days agoA list of top wide moat stocks includes Pfizer Inc. (NYSE:PFE), with its diverse drug portfolio and cost-cutting initiatives. Analysts see potential in Pfizer, but also recommend exploring undervalued...
-
Is Pfizer Inc. (PFE) the Best Future Stock For The Long-Term?
By Yahoo! Finance | 1 week agoAn analysis of Pfizer Inc. (NYSE:PFE) as one of the best future stocks for the long term is provided, citing the company's performance, acquisitions, and operational strategies. The importance of hedg...
-
Jim Cramer on Pfizer Inc. (PFE): 'The Answer Is Yes, Buy More'
By Yahoo! Finance | 1 week agoJim Cramer reviewed top stocks on Mad Money, emphasizing AI's potential but cautioning against inflated claims. He believes AI can enhance customer service and predicts its impact on healthcare and tr...
-
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
By Yahoo! Finance | 1 week agoA list of the 7 Best Stocks for Passive Income includes Pfizer Inc. (NYSE:PFE). Pfizer's consistent dividend growth and attractive yield make it a top choice for passive income investors. Despite rece...
-
Pfizer Inc. (PFE): A Bull Case Theory
By Yahoo! Finance | 2 weeks agoPfizer Inc. is seen as an attractive investment due to its high dividend yield, strong pipeline, and strategic acquisitions. Despite challenges, the company is expected to rebound financially and its ...
-
Is Pfizer Inc. (PFE) The Most Buzzing Stock To Buy Now?
By Yahoo! Finance | 2 weeks agoA recent article discusses the volatility in the stock market during September and October, with experts like Sam Stovall predicting continued market fluctuations. Stovall anticipates multiple interes...
-
Could The Market Be Wrong About Pfeiffer Vacuum Technology AG (ETR:PFV) Given Its Attractive Financial Prospects?
By Yahoo! Finance | 2 weeks agoPfeiffer Vacuum Technology's stock price has dropped, but its strong financials suggest long-term potential. Their ROE of 10% and consistent net income growth align with industry averages, indicating ...
-
Even after rising 3.9% this past week, Pfizer (NYSE:PFE) shareholders are still down 25% over the past three years
By Yahoo! Finance | 2 weeks agoPfizer Inc. (NYSE:PFE) has seen a decline in its share price over the past three years, falling short of market returns. While recent signs show promise, long-term investors have faced challenges. Ana...
-
Is Pfizer Inc. (PFE) The Best Beaten Down Dividend Stock to Invest in Now?
By Yahoo! Finance | 3 weeks agoThe article discusses the appeal of dividend stocks amid market shifts and the impact of interest rate changes. Pfizer Inc. is highlighted as a beaten-down dividend stock with potential, despite chall...
-
Is Pfizer Inc. (PFE) the Best Cancer Stock to Buy Now?
By Yahoo! Finance | 3 weeks agoThe global oncology market is rapidly expanding, with cancer drug spending projected to surpass $300 billion by 2032. Pfizer Inc. (NYSE:PFE) is a key player in the field, offering innovative cancer tr...
-
Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers
By Yahoo! Finance | 1 month agoShort sellers profit from declining stock values through a strategy known as short selling. Despite market highs, short sellers made $10 billion in 2Q 2024. Pfizer Inc. (NYSE:PFE) ranks 7th in afforda...
-
Pfizer Inc. (PFE): Top Contender Among Best Dividend Stocks Under $50
By Yahoo! Finance | 1 month agoThe article evaluates Pfizer Inc. in comparison to other dividend-paying stocks under $50. Despite recent market downturns, analysts remain positive on equity investments, highlighting the potential o...